Brii Bio

Read more
Zhi Hong's photo - President & CEO of Brii Bio

President & CEO

Zhi Hong

CEO Approval Rating

90/100

Founded

2018

Status

PublicIndependent CompanyHong Kong Stock Exchange02137.HK

Social Links

Annual Revenue
<$1M
Employees
98
Funding
$415M

Brii Bio Competitors and Alternatives

1
3
5
7
9
2
4
6
8
10

Brii Bio Quarterly and Annual Revenue

Coming soon for Brii Bio!

Annual Revenue

Brii Bio News

Brii Bio Press Releases

Brii Bio Headquarters

110 Corcoran Street, Office 05-130 One City Center

Durham, North Carolina27701

Driving Directions »

Brii Bio Summary

ABOUT

Overview

Brii Bio is a North Carolina-based biotechnology company that develops and commercializes antibody-derived therapies for the treatment of infectious diseases. Brii Bio was founded in 2018. Brii Bio's headquarters is located in Durham, North Carolina, ...

CEO

Brii Bio's President & CEO, Zhi Hong, currently has an approval rating of 90%. Brii Bio's primary competitors are Variant Bio, Helocyte & Bioplx.

Acquisitions

There have been no acquisitions found related to Brii Bio

Frequently Asked Questions about Brii Bio

  1. When was Brii Bio founded?

    Brii Bio was founded in 2018
  2. Who is Brii Bio's CEO?

    Brii Bio's CEO is Zhi Hong
  3. How much revenue does Brii Bio generate?

    Brii Bio generates $ < 1M in revenue
  4. How much funding does Brii Bio have?

    Brii Bio has historically raised $415M in funding
  5. Where is Brii Bio's headquarters?

    Brii Bio's headquarters is in Durham North Carolina, USA
  1. How many employees does Brii Bio have?

    Brii Bio has 98 employees
  2. What sector does Brii Bio operate in?

    Brii Bio is in Biotechnology, Pharmaceuticals
  3. Who are Brii Bio's competitors?

    Brii Bio's top competitors are Variant Bio, Helocyte, Bioplx
  4. Who has Brii Bio invested in?

    Brii Bio's has invested in companies such as AN2 Therapeutics

Trending Companies